Trade NUVL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nuvalent Inc Class A (NUVL) is trading at US$123.96, up 0.00% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$9.81B. Over the past 52 weeks, NUVL has traded between US$74.40 and US$123.99. On Syfe you can trade NUVL with $0 commission and add it to your watchlist.
| Previous close | US$123.96 |
|---|---|
| Market cap | US$9.81B |
| 52-week range | US$74.40 – US$123.99 |
| Volume | 3.07M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nuvalent Inc Class A
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Year: 2021
GSK Completes $10.6 Billion Acquisition of Nuvalent
Jul 15, 2:16 PM · MT Newswires
GSK Unit Launches Tender Offer for Nuvalent Acquisition
Jun 24, 4:02 PM · MT Newswires
TD Cowen Downgrades Nuvalent to Hold From Buy, Price Target is $124
Jun 10, 11:11 AM · MT Newswires
Guggenheim Downgrades Nuvalent to Neutral From Buy, Adjusts Price Target to $124 From $151
Jun 10, 11:03 AM · MT Newswires
Sector Update: Healthcare Stocks Rise Late Afternoon
Jun 9, 7:43 PM · MT Newswires
Nuvalent Inc Class A (NUVL) stock is trading at US$123.96, 0.00% from the previous close of US$123.96.
The market cap for Nuvalent Inc Class A (NUVL) stock is approximately US$9.81B.
The 52-week high for Nuvalent Inc Class A (NUVL) stock is US$123.99.
The 52-week low for Nuvalent Inc Class A (NUVL) stock is US$74.40.
Nuvalent Inc Class A (NUVL) does not currently pay a dividend.
Stay on top of NUVL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
